LILRB1 and rheumatoid arthritis: In addition to 30 RA patients without detectable LILRB1 recognition, despite substantial levels of circulating sHLA-G molecules, two RA patients revealed sHLA-G molecules in a concentration above 45 ng/ml with a very weak recognition by the LILRB1 receptor.